XML 87 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2021   69,562 10,939          
Beginning balance at Dec. 31, 2021 $ 144,297 $ 6,956 $ (43,847) $ 76,700 $ 0 $ 104,488    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued - stock-based compensation (in shares)   614            
Shares issued - stock-based compensation 312 $ 61   251        
Stock-based compensation expense 2,105     2,105        
Conversion of Liability Awards to Equity 5,336     5,336        
Acquisition of TransGlobe (in shares)   49,307            
Acquisition of TransGlobe 274,145 $ 4,931   269,214        
Treasury stock (in shares)     (691)          
Treasury stock (3,805)   $ (3,805)          
Dividend distributions (9,354)         (9,354)    
Other comprehensive income (loss) 1,179       1,179      
Net income 51,890         51,890    
Endning balance (in shares) at Dec. 31, 2022   119,483 (11,630)          
Ending balance at Dec. 31, 2022 466,105 $ 11,948 $ (47,652) 353,606 1,179 147,024 $ (3,120) $ (3,120)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued - stock-based compensation (in shares)   1,915            
Shares issued - stock-based compensation 674 $ 192   482        
Stock-based compensation expense 3,410     3,410        
Treasury stock (in shares)     (5,421)          
Treasury stock (23,570)   $ (23,570)          
Dividend distributions (26,772)         (26,772)    
Other comprehensive income (loss) 1,701       1,701      
Net income 60,354         60,354    
Endning balance (in shares) at Dec. 31, 2023   121,398 (17,051)          
Ending balance at Dec. 31, 2023 478,782 $ 12,140 $ (71,222) 357,498 2,880 177,486    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued - stock-based compensation (in shares)   906            
Shares issued - stock-based compensation 447 $ 90   357        
Stock-based compensation expense 4,723     4,723        
Treasury stock (in shares)     (1,510)          
Treasury stock (6,802)   $ (6,802)          
Dividend distributions (26,215)         (26,215)    
Other comprehensive income (loss) (7,842)       (7,842)      
Net income 58,490         58,490    
Endning balance (in shares) at Dec. 31, 2024   122,304 (18,561)          
Ending balance at Dec. 31, 2024 $ 501,583 $ 12,230 $ (78,024) $ 362,578 $ (4,962) $ 209,761